A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired <i>cis</i>-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane

<table>Cell viability with chemotherapeutic agents was assessed by MTT assay. RPMI2650CR shows higher resistance to cisplatin that the parental RPMI2650 (a) but has higher sensitivities to both docetaxel (b) and paclitaxel (c).</table>

International Journal of Otolaryngology

fig1

Figure 1

Figure 1: A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired <i>cis</i>-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane 

Figure 1 | A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane 